SSRIs Restore Brain Function in Alzheimer’s
Summary: A new study suggests that SSRIs, commonly prescribed antidepressants, may reduce biological markers of Alzheimer’s disease. In a cohort of 191 individuals, AD patients on SSRIs had lower levels of plasma phosphorylated tau-181, a key indicator of disease severity. Brain scans also showed that SSRIs restored metabolic activity in the dorsal raphe nucleus (DRN), … Read more